02.07.25 -- What Is 'Fit For Use' In AI Models?

Achieve earlier detection of potential adverse cardiac events and refine patient selection for future trial phases by implementing advanced QT monitoring tools.

In 2025, it is likely the clinical trial landscape will be shaped by advancements in artificial intelligence (AI), evolving recruitment strategies, and a renewed focus on equitable access.

Explore the inefficiency of complete SDV and how the adoption of technologies like centralized monitoring, remote SDR, and targeted SDV can enhance data integrity and cost-effectiveness.

See how life science companies are using software as a service (SaaS) to bring new benefits to study startup, data collection, and more with this short blog.

To develop and execute a successful clinical strategy, trial sponsors must be able to rapidly acquire detailed data insights. Learn how you can better utilize your trial data and achieve greater insights.

Explore the challenges of non-enrolling sites in clinical trials, focusing on the benefits of leveraging artificial intelligence (AI) and machine learning (ML) in addressing those issues.

In the ever-evolving landscape of non-interventional clinical studies, the demand for a platform that seamlessly adapts to diverse and increasingly complex research methodologies is critical.

Simplify clinical trial data management with Signant’s Clinical Data Hub. Harness machine learning to aggregate diverse data sources, streamline analysis, and unlock timely, actionable insights.